Does your nose seem to always be stuffed up? Do you have loss of taste or smell? Do you get frequent sinus infections? If so, you may have nasal polyps. Which raises the question: What exactly are ...

Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people worldwide, or about 12% of the population. Defined as a long-lasting ...

With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric ...

Sinus infections aren't contagious on their own, but if a virus causes the sinus infection, that virus might spread from ...

Q: My son has been dealing with chronic sinusitis for years. He thinks that he might have nasal polyps. Can you tell me about this? A: Nasal polyps are soft, painless growths that form in the nasal ...

Nasal polyps are soft, painless growths on the lining of your nasal passages or sinuses, often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead ...

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

Do you ever feel like you're stuck with a perpetual stuffy nose, no matter the time of year or how many tissues you go through? It's like your nose is constantly congested, and you're forced to ...

SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...

The nose is the subject of many sayings. A measurement could be on the nose or an object be right under your nose. You may be reminded to keep your nose clean and keep it out of another's affairs.

LOS ANGELES — For patients with chronic sinusitis and nasal polyps, reslizumab is particularly effective, according to a subgroup analysis of two pivotal phase 3 trials of the anti-interleukin-5 ...

The study met its co-primary endpoints, demonstrating clinically meaningful improvements in both symptom scores.